Modelling of miRNA-mRNA Network to Identify Gene Signatures with Diagnostic and Prognostic Value in Gastric Cancer: Evidence from In-Silico and In-Vitro Studies
- سال انتشار: 1403
- محل انتشار: مجله گزارش های بیوشیمی و زیست شناسی مولکولی، دوره: 13، شماره: 2
- کد COI اختصاصی: JR_RBMB-13-2_015
- زبان مقاله: انگلیسی
- تعداد مشاهده: 178
نویسندگان
Clinical Research Development Unit, Shahid Jalil Hospital, Yasuj University of Medical Sciences, Yasuj, Iran.
Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Cancer Gene Therapy Research Center, Zanjan University of Medical Sciences, Zanjan, Iran & Department of Clinical Biochemistry, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Proteomics Research Center, School of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Proteomics Research Center, School of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran & Zanjan Metabolic Diseases Research Center, Health and Metabolic Diseases Research Institute, Zanjan University of Medical Sciences,
Proteomics Research Center, School of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
چکیده
Background: Gastric cancer (GC) is a prevalent malignancy with high recurrence. Advances in systems biology have identified molecular pathways and biomarkers. This study focuses on discovering gene and miRNA biomarkers for diagnosing and predicting survival in GC patients. Methods: Three sets of genes (GSE۱۹۸۲۶, GSE۸۱۹۴۸, and GSE۱۱۲۳۶۹) and two sets of miRNA expression (GSE۲۶۵۹۵, GSE۷۸۷۷۵) were obtained from the Gene Expression Omnibus (GEO), and subsequently, differentially expressed genes (DEGs) and miRNAs (DEMs) were identified. Functional pathway enrichment, DEG-miR-TF-protein–protein interaction network, DEM-mRNA network, ROC curve, and survival analyses were performed. Finally, qRT-PCR was applied to validate our results. Results: From the high-throughput profiling studies of GC, we investigated ۱۰ candidate mRNA and ۷ candidate miRNAs as potential biomarkers. Expression analysis of these hubs revealed that ۵ miRNAs (including miR-۱۴۱-۳p, miR-۲۰۴-۵p, miR-۳۳۸-۳p, miR-۶۰۹, and miR-۳۶۹-۵p) were significantly upregulated compared to the controls. The genes with the highest degree included ۶ upregulated and ۴ downregulated genes in tumor samples compared to controls. The expression of miR-۱۴۱-۳p, miR-۲۰۴-۵p, SESTD۱, and ANTXR۱ were verified in vitro from these hub DEMs and DEGs. The findings indicated a decrease in the expression of miR-۱۴۱-۳p and miR-۲۰۴-۵p and increased expression of SESTD۱ and ANTXR۱ in GC cell lines compared to the GES-۱ cell line. Conclusions: The current investigation successfully recognized a set of prospective miRNAs and genes that may serve as potential biomarkers for GC's early diagnosis and prognosis.کلیدواژه ها
Biomarker, Gastric cancer, GEO, MicroRNA, PPI-network, Stomach neoplasms.اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.